View highlights and coverage from leading international Endocrinology congresses
We spoke with Teresa Quattrin (University at Buffalo, Oishei Children’s Hospital) following her presentation of the T1GER study, which investigated the effect of treatment with golimumab in children, adolescents, and young adults with newly diagnosed type 1 diabetes. Disclosures: Tersea Quattrin discloses the following: Consultant to Janssen Research & Development Clinical Trial, Principal Investigator at […]
touchENDOCRINOLOGY were delighted to speak with Prof. Hiddo Lambers Heerspink to hear more about the highly anticipated results of DAPA-CKD, investigating dapagliflozin in patients with chronic kidney disease with or without type 2 diabetes. Disclosures: Prof. Lambers Heerspink discloses the following: Grant Funding and Consultancy from AstraZeneca, Boehringer Ingelheim and AbbVie, Steering committee member for […]
We spoke with Dr Ramzi Ajjan (University of Leeds and Leeds Teaching Hospitals Trust) at Virtual EASD 2020 following the presentation of the results from the LIBERATES trial (improving gLucose control in patIents with diaBEtes following myocaRdial infArction: The role of a novEl glycaemic monitoring). Disclosures: Ramzi Ajjan has received institutional research grants from Abbott, […]
We caught up with EASD President Prof. Stefano Del Prato (University of Pisa and University Hospital of Pisa) ahead of this year’s virtual meeting to hear about the key topics being discussed. Disclosures: Prof. Del Prato has received research support from AstraZeneca, Boehringer Ingelheim, Merck Sharp & Dohme and served on the advisory board for […]
We were delighted to speak with EASD President Prof. Stefano Del Prato (University of Pisa and University Hospital of Pisa) ahead of this year’s virtual meeting to hear how the meeting has been adapted to a virtual format. Questions 1. How did you go about planning for virtual EASD?(00:05) 2. What key features are you […]
“It is difficult to evaluate what did not happen.” – Academician, LV Gromashevsky The COVID-19 pandemic may be considered the first global health catastrophe in the past 100 years, since it has affected not only economic, political and medical paradigms, but also our way of life. The rate and distribution of the SARS-CoV-2 virus, despite […]
touchENDOCRINOLOGY caught up with Dr Antonio Ceriello to discuss the European Steering Committee’s ‘A New Era in Diabetes Care’ report and what this means for patients with type 2 diabetes, chronic kidney disease and cardiovascular disease. For further information, please click here for the full report. Questions 1. Please provide a brief overview of the […]
It was a pleasure to speak to Kevin Sayer about the advances in continuous glucose monitoring systems and how these, combined with telemedicine, are helping to optimise support for patients remotely during COVID-19. Questions 1. Please summarise the role of telehealth and the benefits of continuous glucose monitoring (CGM) during the COVID-19 pandemic (0:06) 2. […]
touchENDOCRINOLOGY were delighted to speak to Jose Florez, Committee Chair for the ADA’s Scientific Sessions Meeting Planning Committee, about his highlights of the conference, organising such a large virtual platform, advances in genetics in patients with type 2 diabetes and gestational diabetes and how healthcare biobanks can accelerate clinical research. Questions 1. What were your […]
Get the latest clinical insights from touchENDOCRINOLOGY
